Australia's Incannex hits over one-week high on partnership with Monash University

American Cannabis

11/03/2021 24:50

** Shares of Incannex Healthcare  IHL.AX  rise as much as
5.0% to A$0.210, their highest since March 3 
    ** The medicinal cannabis co partners with Monash
University's Department of Neuroscience in Melbourne to conduct
a study on protective effect of co's IHL-216A drug in sports
concussions  urn:newsml:reuters.com:*:nASX6JfS59
    ** IHL-216A is a drug that comprises cannabidiol (CBD) and
isoflurane
    ** Study to to use model of traumatic brain injury that was
developed in collaboration with the U.S National Football League
to represent type of brain injury that occurs in sports-related
concussions
    ** Stock has risen 29% this year as of last close
    
  

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))